|
1
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thomas H and Coley HM: Overcoming
multidrug resistance in cancer: An update on the clinical strategy
of inhibiting p-glycoprotein. Cancer Control. 10:159–165. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maekawa M, Ishizaki T, Boku S, Watanabe N,
Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K and Narumiya S:
Signaling from Rho to the actin cytoskeleton through protein
kinases ROCK and LIM-kinase. Science. 285:895–898. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohashi K, Nagata K, Maekawa M, Ishizaki T,
Narumiya S and Mizuno K: Rho-associated kinase ROCK activates
LIM-kinase 1 by phosphorylation at threonine 508 within the
activation loop. J Biol Chem. 275:3577–3582. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arber S, Barbayannis FA, Hanser H,
Schneider C, Stanyon CA, Bernard O and Caroni P: Regulation of
actin dynamics through phosphorylation of cofilin by LIM-kinase.
Nature. 393:805–809. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang N, Higuchi O, Ohashi K, Nagata K,
Wada A, Kangawa K, Nishida E and Mizuno K: Cofilin phosphorylation
by LIM-kinase 1 and its role in Rac-mediated actin reorganization.
Nature. 393:809–812. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li R, Doherty J, Antonipillai J, Chen S,
Devlin M, Visser K, Baell J, Street I, Anderson RL and Bernard O:
LIM kinase inhibition reduces breast cancer growth and invasiveness
but systemic inhibition does not reduce metastasis in mice. Clin
Exp Metastasis. 30:483–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Q, Jiao D, Hu H, Song J, Yan J, Wu L
and Xu LQ: Downregulation of LIMK1 level inhibits migration of lung
cancer cells and enhances sensitivity to chemotherapy drugs. Oncol
Res. 20:491–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang H, Wang Y, Xing F, Wang J, Wang Y,
Wang H, Yang Y and Gao Z: Overexpression of LIMK1 promotes
migration ability of multidrug-resistant osteosarcoma cells. Oncol
Res. 19:501–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang HS, Zhao JW, Wang H, Zhang HY, Ji
QY, Meng LJ, Xing FJ, Yang ST and Wang Y: LIM kinase 1 is required
for insulin-dependent cell growth of osteosarcoma cell lines. Mol
Med Rep. 9:103–108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takemura M, Mishima T, Wang Y, Kasahara J,
Fukunaga K, Ohashi K and Mizuno K:
Ca2+/calmodulin-dependent protein kinase IV-mediated LIM
kinase activation is critical for calcium signal-induced neurite
outgrowth. J Biol Chem. 284:28554–28562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao JW, Zhang MR, Ji QY, Xing FJ, Meng LJ
and Wang Y: The role of slingshot-1L (SSH1L) in the differentiation
of human bone marrow mesenchymal stem cells into cardiomyocyte-like
cells. Molecules. 17:14975–14994. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Peng X, Yu W, Hou S, Zhao Y,
Zhang Z, Huang X and Wu K: Alpha-tocopheryl succinate enhances
doxorubicin-induced apoptosis in human gastric cancer cells via
promotion of doxorubicin influx and suppression of doxorubicin
efflux. Cancer Lett. 307:174–181. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davila M, Frost AR, Grizzle WE and
Chakrabarti R: LIM kinase 1 is essential for the invasive growth of
prostate epithelial cells: Implications in prostate cancer. J Biol
Chem. 278:36868–36875. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tapia T, Ottman R and Chakrabarti R: LIM
kinase1 modulates function of membrane type matrix
metalloproteinase 1: Implication in invasion of prostate cancer
cells. Mol Cancer. 10:62011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang TY, DerMardirossian C and Bokoch GM:
Cofilin phosphatases and regulation of actin dynamics. Curr Opin
Cell Biol. 18:26–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo H, Wu F, Wang Y, Yan C and Su W:
Overexpressed ubiquitin ligase Cullin7 in breast cancer promotes
cell proliferation and invasion via down-regulating p53. Biochem
Biophys Res Commun. 450:1370–1376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kathawala RJ, Gupta P, Ashby CR Jr and
Chen ZS: The modulation of ABC transporter-mediated multidrug
resistance in cancer: A review of the past decade. Drug Resist
Updat. 18:1–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: State of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang JZ, Ma SR, Rong XL, Zhu MJ, Ji QY,
Meng LJ, Gao YY, Yang YD and Wang Y: Characterization of
multidrug-resistant osteosarcoma sublines and the molecular
mechanisms of resistance. Mol Med Rep. 14:3269–3276. 2016.
View Article : Google Scholar : PubMed/NCBI
|
